GLP-1 medications target a single hormone pathway (GLP-1) that influences appetite, digestion, and blood sugar regulation. GIP/GLP-1 dual agonists like tirzepatide, on the other hand, target two hormone pathways at once (both GIP and GLP-1). Because they act on both, they may produce different results for some patients.
Still Questions? Contact Support